PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach ...

Shares of Viatris Inc. VTRS slipped 3.76% to $8.95 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.16% to 5,776.65 ...

Shares of Viatris Inc. VTRS shed 3.07% to $9.15 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.08% to 5,667.56 and ...

In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other best stocks to buy according to billionaire David Einhorn. David Einhorn is a highly regarded ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other best weight loss drug stocks to buy according to analysts. Most people have tried to include ...

In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other large-cap stocks. The big and large-cap stocks have spearheaded the rally in the past two ...

Today, VTRS has 4 main geographic divisions: Developed Markets, Greater China, JANZ, and Emerging Markets. Lipitor, Celebrex, EpiPen and many other brand names are part of the combined entity ...

Looking at the universe of stocks we cover at Dividend Channel, on 3/10/25, Evergy Inc (Symbol: EVRG), Viatris Inc (Symbol: VTRS), and Becton, Dickinson & Co (Symbol: BDX) will all trade ex ...

For the quarter ended December 2024, Viatris (VTRS) reported revenue of $3.53 billion, down 8.1% over the same period last year. EPS came in at $0.54, compared to $0.61 in the year-ago quarter.

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

Head of development Marilyn Storey says international healthcare company Viatris has signed a 10-year lease for the first building and will move in early next year. She says the tenant will have ...